Skip to content

Construction and Effectiveness Evaluation of an Artificial Intelligence–based Postpartum Follow-up Model for Postpartum Women with Gestational Diabetes Mellitus

Construction and Effectiveness Evaluation of an Artificial Intelligence–based Postpartum Follow-up Model for Postpartum Women with Gestational Diabetes Mellitus

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127384
Enrollment
Unknown
Registered
2026-06-30
Start date
2026-07-16
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Interventions

AI Follow-up Group:Input patients’ baseline data ? The system automatically generates personalized follow-up tasks combined with the knowledge base ? Initiate follow-up after double-person review ? Au
Conventional Follow-up Group:The conventional follow-up group was administered AI telephone follow-up in accordance with standard fixed hospital communication protocols.

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosed with GDM via 75g oral glucose tolerance test (OGTT); 2.aged 18 years or older; 3.singleton pregnancy; 4.fetal cephalic presentation; 5.intact cognitive, reading and writing abilities with unobstructed communication; 6.signed informed consent, voluntary participation and willingness to complete full follow-up and related indicator tests.

Exclusion criteria

Exclusion criteria: 1.Pre-gestational diagnosed diabetes mellitus (type 1 or type 2); 2. complicated with severe cardiac, hepatic, renal dysfunction or mental disorders such as schizophrenia and major depressive episode; 3.suffering from language, hearing, reading or writing disorders that hinder AI interaction and questionnaire completion; 4.participation in other interventional clinical trials; 5.planned hospital transfer for delivery during follow-up or inability to cooperate with follow-up procedures.

Design outcomes

Primary

MeasureTime frame
75g OGTT re-examination completion rate;

Secondary

MeasureTime frame
Completion rate of follow-up at various postpartum time points;Recognition and successful manual referral rate of high-risk & abnormal symptoms;Average follow-up time per person;Self-management ability of postpartum women with GDM;Anxiety-depression status;System usability evaluation;

Countries

China

Contacts

Public ContactSu Lin

Affiliated Hospital of North Sichuan Medical College

linsu0621@163.com+86 177 6678 3920

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026